# Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial

> **NCT01706627** · PHASE2,PHASE3 · COMPLETED · sponsor: **Khon Kaen University** · enrollment: 175 (actual)

## Conditions studied

- Advanced Stage Cancer

## Interventions

- **DRUG:** 10 mg Melatonin
- **DRUG:** 20 mg Melatonin
- **DRUG:** Matched placebo

## Key facts

- **NCT ID:** NCT01706627
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2012-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706627, "Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01706627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*